Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis
- DOI
- 10.1016/j.esmoop.2026.108248
- Published
- 2026-07
- Container
- ESMO Open
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.108248,
title = {Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis},
author = {S. Camera and A. Vogel and M. Rimini and M. Ikeda and O. Abidoye and J. Lucchetti and L. Antonuzzo and J.W. Kim and F. Nichetti and A. Saborowski and T. Pressiani and C. Vivaldi and I.G. Rapposelli and F. Peeters and C. Braconi and D.J. Pinato and E. Tamburini and C. Pircher and S. Tamberi and F. Castet and M. Verrico and A. Parisi and N. Couto and H.J. Chon and A. Martirena and A. Lamarca and M. Landriscina and F. Finkelmeier and E. Oneda and A. Avallone and E. Dell’Aquila and L. Perkhofer and I.H. Kim and V. Formica and C.M. de Sousa Pinto and I. Garajova and B. Kang and S. Corallo and E. Fenocchio and G. Farinea and A. Pastorino and A. Diana and Y. Changhoon and M. Schirripa and M.G. Rodriquenz and M. Scartozzi and L. Zumstein and M. Ghidini and G.W. Prager and G. Aprile and G.P. Spinelli and S. Yung-Yeh and S.L. Chan and E. Warmington and A. Lancianese and T. Satake and T. Bekaii-Saab and G. Giordano and D. Lavacchi and L. Passeri and M. Ferrara and F. Rossari and F. Lo Prinzi and M. Kang and A.A. Prete and S. Bozzarelli and M. Persano and G. Masi and R. Balsano and M. Niger and S. Lonardi and F. Salani and L. Fornaro and L. Rimassa and A. Casadei-Gardini},
year = {2026},
journal = {ESMO Open},
doi = {10.1016/j.esmoop.2026.108248},
url = {https://doi.org/10.1016/j.esmoop.2026.108248}
}RIS
TY - JOUR TI - Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis AU - S. Camera AU - A. Vogel AU - M. Rimini AU - M. Ikeda AU - O. Abidoye AU - J. Lucchetti AU - L. Antonuzzo AU - J.W. Kim AU - F. Nichetti AU - A. Saborowski AU - T. Pressiani AU - C. Vivaldi AU - I.G. Rapposelli AU - F. Peeters AU - C. Braconi AU - D.J. Pinato AU - E. Tamburini AU - C. Pircher AU - S. Tamberi AU - F. Castet AU - M. Verrico AU - A. Parisi AU - N. Couto AU - H.J. Chon AU - A. Martirena AU - A. Lamarca AU - M. Landriscina AU - F. Finkelmeier AU - E. Oneda AU - A. Avallone AU - E. Dell’Aquila AU - L. Perkhofer AU - I.H. Kim AU - V. Formica AU - C.M. de Sousa Pinto AU - I. Garajova AU - B. Kang AU - S. Corallo AU - E. Fenocchio AU - G. Farinea AU - A. Pastorino AU - A. Diana AU - Y. Changhoon AU - M. Schirripa AU - M.G. Rodriquenz AU - M. Scartozzi AU - L. Zumstein AU - M. Ghidini AU - G.W. Prager AU - G. Aprile AU - G.P. Spinelli AU - S. Yung-Yeh AU - S.L. Chan AU - E. Warmington AU - A. Lancianese AU - T. Satake AU - T. Bekaii-Saab AU - G. Giordano AU - D. Lavacchi AU - L. Passeri AU - M. Ferrara AU - F. Rossari AU - F. Lo Prinzi AU - M. Kang AU - A.A. Prete AU - S. Bozzarelli AU - M. Persano AU - G. Masi AU - R. Balsano AU - M. Niger AU - S. Lonardi AU - F. Salani AU - L. Fornaro AU - L. Rimassa AU - A. Casadei-Gardini PY - 2026 JO - ESMO Open DO - 10.1016/j.esmoop.2026.108248 UR - https://doi.org/10.1016/j.esmoop.2026.108248 ER -
APA
Camera, S., Vogel, A., Rimini, M., Ikeda, M., Abidoye, O., Lucchetti, J., Antonuzzo, L., Kim, J., Nichetti, F., Saborowski, A., Pressiani, T., Vivaldi, C., Rapposelli, I., Peeters, F., Braconi, C., Pinato, D., Tamburini, E., Pircher, C., Tamberi, S., Castet, F., Verrico, M., Parisi, A., Couto, N., Chon, H., Martirena, A., Lamarca, A., Landriscina, M., Finkelmeier, F., Oneda, E., Avallone, A., Dell’Aquila, E., Perkhofer, L., Kim, I., Formica, V., Pinto, C. D. S., Garajova, I., Kang, B., Corallo, S., Fenocchio, E., Farinea, G., Pastorino, A., Diana, A., Changhoon, Y., Schirripa, M., Rodriquenz, M., Scartozzi, M., Zumstein, L., Ghidini, M., Prager, G., Aprile, G., Spinelli, G., Yung-Yeh, S., Chan, S., Warmington, E., Lancianese, A., Satake, T., Bekaii-Saab, T., Giordano, G., Lavacchi, D., Passeri, L., Ferrara, M., Rossari, F., Prinzi, F. L., Kang, M., Prete, A., Bozzarelli, S., Persano, M., Masi, G., Balsano, R., Niger, M., Lonardi, S., Salani, F., Fornaro, L., Rimassa, L., & Casadei-Gardini, A. (2026). Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis. ESMO Open. https://doi.org/10.1016/j.esmoop.2026.108248
Source records
- crossref · retrieved 2026-09-26T03:22:17.827Z